Skip to content

TG THERAPEUTICS, INC.

TGTX

CIK 0001001316

← back to feed
Revenue (TTM)
$628.63M
+87.3% YoY Q1 May 2026
Net Income (TTM)
$443.92M
+1,812.4% YoY Q1 May 2026
EPS Diluted (TTM)
$2.75
+1,746.7% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
17.1%
Q1 May 2026
Net Margin
70.6%
Q1 May 2026
Free Cash Flow (TTM)
−$114.8M
Q1 May 2026
Cash
$442.21M
Q1 May 2026
Total Debt
$745.14M
Q1 May 2026
Shares Outstanding
153.08M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings